<DOC>
	<DOC>NCT02952716</DOC>
	<brief_summary>The effects and safety of Human cord blood mononuclear cell for delayed encephalopathy after carbon monoxide poisoning</brief_summary>
	<brief_title>Treatment of Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning</brief_title>
	<detailed_description>To evaluate the effect and mechanism of human cord blood mononuclear cell transplantation for delayed encephalopathy after carbon monoxide poisoning</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Poisoning</mesh_term>
	<mesh_term>Carbon Monoxide Poisoning</mesh_term>
	<mesh_term>Carbon Monoxide</mesh_term>
	<criteria>3560 years old. No serious infection, chronic diseases, diabetes and tuberculosis. Written informed consents were obtained from all subjects. Symptomatic Delayed Encephalopathy After Carbon Monoxide Poisoning. The heart, liver, kidney and other viscera serious organic disease. Allergic constitution, clotting disorders, autoimmune diseases and tumors. Pregnancy. Moribund patient. History of prior brain injury. History of central nervous system disease.</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>carbon monoxide poisoning</keyword>
	<keyword>delayed encephalopathy</keyword>
</DOC>